MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN Company MERCK Kommanditgesellschaft auf Aktien Other OTC
Equities
MKKGY
US5893392093
Pharmaceuticals
Business Summary
- solutions and products for scientific and biotechnological research (44.2%);
- pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.;
- performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc.
Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Sales per Business
| EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Life Science
44.2
%
| 10,380 | 46.7 % | 9,281 | 44.2 % | -10.59% |
Healthcare
38.4
%
| 7,839 | 35.3 % | 8,053 | 38.4 % | +2.73% |
Electronics
17.4
%
| 4,013 | 18.1 % | 3,659 | 17.4 % | -8.82% |
Sales per region
| EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
United States
28.2
%
| 6,302 | 28.3 % | 5,911 | 28.2 % | -6.20% |
Europe
21.0
%
| 4,524 | 20.3 % | 4,402 | 21.0 % | -2.70% |
Asia Pacific
19.9
%
| 4,479 | 20.1 % | 4,181 | 19.9 % | -6.65% |
China
11.8
%
| 2,818 | 12.7 % | 2,477 | 11.8 % | -12.10% |
Germany
6.8
%
| 1,532 | 6.9 % | 1,420 | 6.8 % | -7.31% |
Latin America
6.0
%
| 1,175 | 5.3 % | 1,267 | 6.0 % | +7.83% |
Middle East and Africa
2.5
%
| 516 | 2.3 % | 535 | 2.5 % | +3.68% |
Switzerland
2.4
%
| 592 | 2.7 % | 512 | 2.4 % | -13.51% |
North America
1.4
%
| 294 | 1.3 % | 287 | 1.4 % | -2.38% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 13/20/13 | |
Marcus Kuhnert
DFI | Director of Finance/CFO | 56 | 01/14/01 |
| Director of Finance/CFO | 53 | 26/19/26 | |
Laura Matz
CTO | Chief Tech/Sci/R&D Officer | - | 01/19/01 |
Danny Bar-Zohar
CTO | Chief Tech/Sci/R&D Officer | - | 01/20/01 |
Constantin Fest
IRC | Investor Relations Contact | - | - |
Jeff White
PRN | Corporate Officer/Principal | - | - |
Andrew Paterson
SAM | Sales & Marketing | - | - |
| Corporate Officer/Principal | - | 01/21/01 | |
Hong Chow
PRN | Corporate Officer/Principal | 53 | 01/21/01 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 75 | 09/14/09 | |
Christian Raabe
BRD | Director/Board Member | - | - |
| Chairman | 67 | 26/19/26 | |
Gabriele Eismann
BRD | Director/Board Member | 62 | 01/91/01 |
Dietmar Oeter
BRD | Director/Board Member | 57 | 01/95/01 |
Barbara Lambert
BRD | Director/Board Member | 62 | 11/23/11 |
Renate Koehler
BRD | Director/Board Member | - | 26/19/26 |
| Director/Board Member | - | 26/19/26 | |
Daniel Thelen
BRD | Director/Board Member | - | 26/19/26 |
Simon Thelen
BRD | Director/Board Member | 44 | 26/19/26 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 305,535,626 | 0 | 0 | 29.71 % |
| Stock B | 1 | 129,242,252 | 129,159,619 ( 99.94 %) | 0 |
Holdings
| Name | Equities | % | Valuation |
|---|---|---|---|
| 2,787,509 | 4.65% | 117,772,255 $ | |
PT MERCK TBK 86.65% | 388,194,920 | 86.65% | 97,405,869 $ |
VERA THERAPEUTICS, INC. 3.48% | 1,913,501 | 3.48% | 74,033,354 $ |
PRECIGEN, INC. 8.29% | 20,647,152 | 8.29% | 28,906,013 $ |
Company contact information
Group companies
| Name | Category and Sector |
|---|---|
Ridgefield Holdco SARL
| |
Merck Specialities Pvt Ltd.
 Merck Specialities Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck Specialities Pvt Ltd. is a pharmaceutical manufacturing and Indian distribution company. The company is based in Mumbai, India and was founded in 2005. |
Pharmaceuticals: Major
|
Merck Finanz SARL
 Merck Finanz SARL Medical/Nursing ServicesHealth Services Part of Merck KGaA, Merck Finanz SARL is a Luxembourger company that provides healthcare, life sciences, and electronic services. The company is based in Luxembourg, Luxembourg. |
Medical/Nursing Services
|
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. |
Medical Specialties
|
Merck Electronics KGaA
| |
Merck Life Science UK Ltd.
 Merck Life Science UK Ltd. Chemicals: Major DiversifiedProcess Industries Founded in 1960, Merck Life Science UK Ltd. is a subsidiary of Merck KGaA. The company is based in Gillingham, UK. The British company provides advanced chemical materials for the manufacturing of LCD panels. |
Chemicals: Major Diversified
|
Merck BV
| |
Merck Life Science A/S
 Merck Life Science A/S Electronic Equipment/InstrumentsElectronic Technology Part of Merck KGaA, Merck Life Science A/S is a Danish company that provides industrial instruments for measurement. The company is located in Denmark. |
Electronic Equipment/Instruments
|
Merck Santé SASU
 Merck Santé SASU Pharmaceuticals: MajorHealth Technology Merck Santé SAS manufactures pharmaceutical products. The company is headquartered in Lyon, France. |
Pharmaceuticals: Major
|
Sector
Sales per Business
Sales per region
| 1st Jan change | Capi. | |
|---|---|---|
| +10.49% | 895.73Cr | |
| -10.76% | 518.56Cr | |
| +54.31% | 476.76Cr | |
| +11.19% | 426.22Cr | |
| -22.37% | 236.89Cr | |
| +12.49% | 229.5Cr | |
| -30.09% | 220.86Cr | |
| +20.63% | 217.28Cr | |
| -0.50% | 164.41Cr |
